| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0002 |